characteristics.text: SAMN33603030
characteristics.characteristic: External Id
characteristics.text: Novartis Institutes for BioMedical Research
characteristics.characteristic: INSDC center name
characteristics.text: 2024-02-01T00:52:09.883Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-02-01T00:52:09.883Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS16959744
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Model organism or animal
characteristics.characteristic: NCBI submission model
characteristics.text: Model.organism.animal.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS16959744
characteristics.characteristic: SRA accession
characteristics.text: 9 weeks
characteristics.characteristic: age
characteristics.text: B6.Cg-Foxp3tm2Tch/J
characteristics.characteristic: breed
characteristics.text: Infected animals were inoculated with an intraperitoneal injection of 5000 T. cruzi trypomastigotes (Tulahuén Strain). Trypomastigotes were obtained from the blood of previously infected CD1 male mice. At the time of their sacrifice, Foxp3-GFP mice were 15 days post infection. No drugs were coadministered.
characteristics.characteristic: description
characteristics.text: Mus musculus
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_10090
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: skeletal muscle - quadriceps
characteristics.characteristic: tissue
characteristics.text: Model organism or animal sample from Mus musculus
characteristics.characteristic: title
characteristics.text: No infection - mouse #3
characteristics.characteristic: treatment